Systematic review of exposure to albendazole or mebendazole during pregnancy and effects on maternal and child outcomes, with particular reference to exposure in the first trimester

This publication has 61 references indexed in Scilit:

• Impact of Anthelminthic Treatment in Pregnancy and Childhood on Immunisations, Infections and Eczema in Childhood: A Randomised Controlled Trial
  PLOS ONE, 2012
• Exposure to Mebendazole and Pyrvinium during Pregnancy: A Danish Nationwide Cohort Study
  Infectious Diseases in Obstetrics and Gynecology, 2012
• The Effect of Anthelmintic Treatment During Pregnancy on HIV Plasma Viral Load
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
• CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
  International Journal of Surgery, 2012
• The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
  BMJ, 2011
• Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised‐controlled trial results
  Pediatric Allergy and Immunology, 2011
• Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial
  The Lancet, 2011
• Effects of Deworming during Pregnancy on Maternal and Perinatal Outcomes in Entebbe, Uganda: A Randomized Controlled Trial
  Clinical Infectious Diseases, 2010
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
  PLOS Medicine, 2007
• A double‐blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm‐endemic area of Peru
  Tropical Medicine & International Health, 2006